Edwards LA

Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial.

Patel VC, Lee S, McPhail MJW, ..., Shoaie S, Shawcross DL

J Hepatol 76 (2) 332-342 [2022-02-00; online 2021-09-24]

Saeed Shoaie SciLifeLab Fellow

Global and temporal state of the human gut microbiome in health and disease

Shoaie S, Lee S, Almeida M, ..., Ehrlich S, Uhlen M

- - (-) - [2021-04-01; online 2021-04-01]